eli lilly retatrutide clinical trials VisualAbstract: reduces body weight by 17.5% in patients with obesity Retatrutide, Eli Lilly’s Next-Gen Obesity

Nurse practitioners face a patchwork of scope-of-practice laws: Full Practice Authority (FPA) states (~26 states plus D.C.): You can prescribe independently, including weight-loss medications, without physician oversight

Vegetables and Fruits: Organic or Conventional

A note on GLP-1 agonists for weight loss Though GLP-1 agonists can be beneficial for weight loss, its important to keep in mind that there is limited research on the long-term effects of these medications

It has also been reported that circulating levels of GLP-1 were correlated with coronary artery atherosclerosis

Right now, people who are prescribed GLP-1s have some kind of risk factor for Alzheimers, whether its being overweight, obesity, or type 2 diabetes

These medications provide a non-invasive yet effective option for those struggling with weight regain after VSG, making them an essential component of any comprehensive treatment plan